Nutraceuticals in the Management of Cardiovascular Risk Factors: Where is the Evidence?

Author(s):  
Cody Russell ◽  
Suresh Keshavamurthy ◽  
Sibu Saha

: Cardiovascular disease continues to rise at an alarming rate, and research focuses on possible therapies to reduce the risk and slow down its progression. Several epidemiological studies have indicated that dietary modifications, such as increased consumption of fruits and vegetables play an important role in reducing cardiovascular disease risk factors. Food sources rich in antioxidants, anti-inflammatory, hypolipidemic, and hypoglycemic properties are thought to ameliorate the progression of cardiovascular disease and serve as a potential treatment mode. Many in vivo and in vitro studies using turmeric, cinnamon, mango, blueberries, red wine, chocolate, and extra virgin olive oil have demonstrated significant improvements in cholesterol profiles, toxic reactive oxygen species, inflammation, obesity, and hypertension. In this review, we summarize recent evidence on the cardioprotective effect of different food groups, outline their potential mechanisms involved in slowing down the progression of cardiovascular disease, and highlight the beneficial effects associated with increased consumption.

2020 ◽  
Vol 29 (1) ◽  
pp. 60-70
Author(s):  
Kyong-Tae Kim ◽  
Ki-Hyuk Lee

PURPOSE: The purpose of this study was to investigate the influence of combined exercise and extra virgin olive oil supplement on health-related physical fitness, cardiovascular disease risk factors, and bone density in obese elementary school students.METHODS: The participants were 40 obese elementary students over 25 kg/m<sup>2</sup> to BMI, 10 combined exercise with high olive oil supplement group (HO+CE), 10 combined exercise with low olive oil supplement group (LO+CE), 10 combined exercise with placebo group (PL+CE), and 10 placebo group (PL). The participants have performed the exercise program for 70 minutes a day and 3 times a week with aerobic and resistance exercise during 12 weeks. Also, high and low olive oil supplement group took in 25 g and 10 g respectively at the same time and place.RESULTS: There were significant decreases in body fat to HO+CE compared with PL+CE (<i>p</i><.05) and significant increase in muscle mass and muscular endurance compared with PL+CE (<i>p</i><.05). However, there were no significant differences in body weight, BMI, muscular strength, and flexibility between groups. For cardiovascular disease risk factors, there is a significant difference to triglyceride, LDL-C, total cholesterol in HO+CE compared with PL+CE (<i>p</i><.05) and there were significant differences to HDL-C significantly decreased in HO+CE compared with PL+CE (<i>p</i><.05). There is no significant difference in bone density between groups (<i>p</i>>.05).CONCLUSIONS: In conclusion, there were positive responses for body composition and cardiovascular disease risk factors for the twofold cases through combined exercise and high extra virgin olive oil supplement, but not for bone density.


2021 ◽  
Author(s):  
Moataz Dowaidar

CRISPR/Cas9 systems, in particular, have emerged as an important and promising technology for in vitro and in vivo genomic manipulation. Although genome editing has been used in the cardiovascular community as a scientific tool to study disease pathogenesis, therapeutic genome editing has yet to be used in clinical practice. PCSK9 is one of the most promising therapeutic genome editing candidates in the liver, and it has been thoroughly studied for cardiovascular disease risk reduction. Despite this, owing to the inefficiency of current genome editing technologies and distribution systems in the heart, treating the heart remains challenging. We should expect a steady stream of new editing approaches targeting wider use, given that clinical genome editing is still in its early stages but is rapidly progressing. It would be necessary to develop safe and reliable distribution systems in order to use such creative approaches in clinical settings.


Diabetes ◽  
2018 ◽  
Vol 67 (Supplement 1) ◽  
pp. 1491-P
Author(s):  
APRILL DAWSON ◽  
EMMA GARACCI ◽  
MUKOSO N. OZIEH ◽  
REBEKAH J. WALKER ◽  
LEONARD E. EGEDE

Sign in / Sign up

Export Citation Format

Share Document